Elsevier

Gynecologic Oncology

Volume 101, Issue 3, June 2006, Pages 476-480
Gynecologic Oncology

Gender of offspring and maternal ovarian cancer risk

https://doi.org/10.1016/j.ygyno.2005.11.008Get rights and content

Abstract

Objective.

A single live birth compared to nulliparity significantly reduces the risk for ovarian cancer, but exactly how pregnancy reduces ovarian cancer risk is unknown. We sought to determine whether offspring gender, which differentially alters maternal hormonal milieu, may be associated with maternal ovarian cancer risk.

Methods.

Parous women (n = 511) with incident ovarian cancer were compared to parous community controls (n = 1136) participating in a population-based case-control study of ovarian cancer (Delaware Valley, 1994–1998). In subgroup specific models for women with one, two, or three births, multivariate logistic regression was used to assess the relationship between ovarian cancer and offspring gender, adjusting for age, race, education, oral contraceptives, breast feeding, tubal ligation, and ovarian cancer family history.

Results.

Compared to having all girls, women with all boys tended to have a reduced risk of ovarian cancer (OR = 0.80 95% CI: 0.58, 1.10), while women with boys and girls conferred the greatest protection (OR = 0.58, 95% CI: 0.43, 0.79). Among women with two births, the association was observed for those with one boy and one girl (OR = 0.63, 95% CI: 0.40, 1.00), but not for those with two male offspring (OR = 1.12, 95% CI: 0.68, 1.85). This result was consistent among women with three births (OR = 0.42, 95% CI: 0.21, 0.84; OR = 0.47, 95% CI: 0.23, 0.95; OR = 0.49, 95% CI: 0.20, 1.21; for one, two, and three boys, respectively, compared to all girls).

Conclusion.

Compared to having all girls, bearing both male and female offspring may be associated with a decrease in maternal ovarian cancer risk, although the biologic relevance of this observation is unclear.

Introduction

Ovarian cancer is responsible for more deaths than any other cancer of the female reproductive system, with less than 50% of women in the United States surviving 5 years after diagnosis [1]. It is estimated that 22,220 American women will be diagnosed with ovarian cancer in the year 2005, and approximately 16,210 of these women will die [1], due, in part, to the lack of effective prevention and early detection methods. Increased understanding of the etiology of ovarian cancer may inform preventative strategies.

It is well-documented that a single live birth compared to nulliparity substantially reduces the risk for ovarian cancer, and the risk declines for each additional full-term pregnancy [2]. Exactly how pregnancy reduces ovarian cancer risk is unknown. Several hypotheses posed to explain the association include: reduction in number of ovulations [3], lower circulating gonadotropins [4], reduced inflammation [5], and altered circulating steroid hormones [6].

Fetal sex differentially alters the maternal hormonal milieu during normal pregnancy [7], [8], [9], [10], [11], [12], [13]. In particular, circulating concentrations of estriol [14], alpha-fetoprotein, and human chorionic gonadotropin [7], [8], [9], [10], [13] are lower in mothers of male fetuses; whether these differences relate to ovarian cancer risk is unknown. Since fetal sex is associated with some circulating maternal hormones, it is possible that an altered hormonal milieu might modify the protective effect of childbearing on hormonally linked cancers such as ovarian cancer. Epidemiologic studies of offspring gender and ovarian cancer risk are lacking. Bearing male offspring was associated with a reduced risk of breast cancer, another hormonally-related cancer, in one study [15], although not consistently [16], [17], [18], [19]. These observations led us to investigate the association between offspring gender and maternal ovarian cancer risk in a large population-based case-control study of ovarian cancer.

Section snippets

Materials and methods

The SHARE (Study of Health and Reproduction) study design and methodology have been described in detail [5], [20]. Briefly, SHARE is a population-based, case-control study of contraceptive and reproductive risk factors for epithelial ovarian cancer. Cases were women age 20 to 69 with a diagnosis of incident epithelial ovarian cancer within the 6 months prior to interview. Eligible cases (n = 873) were identified from 39 hospitals around the Delaware Valley from May 1994 to July 1998. Fourteen

Results

Among the 511 cases, 82% of the tumors were categorized as invasive. The classification of the histologic types was as follows: serous, 48%; endometroid, 18%; mucinous, 14%; clear cell, 5%; other, 15%. This distribution of histologic types is consistent with that observed in other studies [23], [24], [25]. Table 1 shows the demographic and reproductive risk factor data for the 511 cases and 1136 controls with at least one singleton birth. Case-control differences were generally consistent with

Discussion

In this study, we investigated the association between gender of offspring and epithelial ovarian cancer. Overall, our data suggest that compared to having all girls, bearing both male and female offspring may be associated with a decrease in maternal ovarian cancer risk.

The length of the follicular phase and the hormone concentration at the time of conception are believed to influence the sex ratio [26], [27]. To our knowledge, only one previous study has evaluated the association between

Acknowledgments

This work was supported by contracts from: R01CA61095 (NCI), KO7-CA80668 (NCI), DAMD17-00-1-0569 (DOD).

References (28)

  • M.F. Fathalla

    Incessant ovulation—A factor in ovarian neoplasia? (letter)

    Lancet

    (1971)
  • H. Danzer et al.

    Maternal serum human chorionic gonadotropin concentrations and fetal sex prediction

    Fertil. Steril.

    (1980)
  • A. Jemal et al.

    Cancer statistics, 2005

    CA Cancer J. Clin.

    (2005)
  • A.S. Whittemore et al.

    Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

    Am. J. Epidemiol.

    (1992)
  • D.W. Cramer et al.

    Determinants of ovarian cancer risk: II. Inferences regarding pathogenesis

    J. Natl. Cancer Inst.

    (1983)
  • R.B. Ness et al.

    Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer

    Epidemiology

    (2000)
  • H.A. Risch

    Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

    J. Natl. Cancer Inst.

    (1998)
  • K. Bremme et al.

    Outcome of pregnancy in relation to maternal serum alpha-fetoprotein levels in the second trimester. An evaluation of a screening program and a longitudinal follow-up

    Gynecol. Obstet. Invest.

    (1988)
  • R.J. Chen et al.

    Fetal sex and maternal alpha-fetoprotein concentration at late normal singleton pregnancies

    Acta Obstet. Gynecol. Scand.

    (1994)
  • J.A. Steier et al.

    Correlation between fetal sex and human chorionic gonadotropin in peripheral maternal blood and amniotic fluid in second and third trimester normal pregnancies

    Acta Obstet. Gynecol. Scand.

    (1999)
  • Y.H. Lam et al.

    The effect of fetal gender on second-trimester maternal serum inhibin—A concentration

    Prenat. Diagn.

    (2001)
  • M. Chellakooty et al.

    Longitudinal study of serum placental GH in 455 normal pregnancies: correlation to gestational age, fetal gender, and weight

    J. Clin. Endocrinol. Metab.

    (2002)
  • Y. Yaron et al.

    Maternal serum HCG is higher in the presence of a female fetus as early as week 3 post-fertilization

    Hum. Reprod.

    (2002)
  • R. Troisi et al.

    Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States)

    Cancer Causes Control

    (2003)
  • Cited by (0)

    View full text